A detailed history of Capital Impact Advisors, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Capital Impact Advisors, LLC holds 12,572 shares of EXAS stock, worth $885,697. This represents 1.52% of its overall portfolio holdings.

Number of Shares
12,572
Previous 21,279 40.92%
Holding current value
$885,697
Previous $1.47 Million 63.85%
% of portfolio
1.52%
Previous 1.96%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 16, 2024

SELL
$41.33 - $74.26 $359,860 - $646,581
-8,707 Reduced 40.92%
12,572 $531,000
Q1 2024

May 15, 2024

BUY
$56.27 - $73.77 $708,157 - $928,395
12,585 Added 144.76%
21,279 $1.47 Million
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $270,731 - $347,100
4,584 Added 111.53%
8,694 $643,000
Q2 2023

Aug 14, 2023

SELL
$62.68 - $95.05 $47,448 - $71,952
-757 Reduced 15.55%
4,110 $385,000
Q1 2023

May 23, 2023

SELL
$47.19 - $70.77 $75,928 - $113,868
-1,609 Reduced 24.85%
4,867 $330,000
Q4 2022

Feb 14, 2023

BUY
$30.35 - $53.15 $31,655 - $55,435
1,043 Added 19.2%
6,476 $320,000
Q3 2022

Nov 21, 2022

BUY
$31.97 - $49.37 $83,505 - $128,954
2,612 Added 92.59%
5,433 $201,000
Q2 2022

Aug 15, 2022

SELL
$35.61 - $76.23 $144,291 - $308,883
-4,052 Reduced 58.96%
2,821 $111,000
Q1 2022

May 16, 2022

BUY
$57.56 - $82.54 $395,609 - $567,297
6,873 New
6,873 $481,000
Q4 2021

Feb 14, 2022

SELL
$72.5 - $100.68 $971,500 - $1.35 Million
-13,400 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$90.24 - $124.05 $3.07 Million - $4.22 Million
-33,988 Reduced 71.72%
13,400 $1.28 Million
Q2 2021

Aug 17, 2021

BUY
$93.66 - $139.27 $3.55 Million - $5.27 Million
37,854 Added 397.04%
47,388 $5.4 Million
Q1 2021

May 18, 2021

SELL
$116.57 - $155.01 $7.01 Million - $9.33 Million
-60,168 Reduced 86.32%
9,534 $1.26 Million
Q4 2020

Feb 12, 2021

BUY
$99.61 - $142.12 $498,050 - $710,600
5,000 Added 7.73%
69,702 $9.24 Million
Q3 2020

Nov 13, 2020

BUY
$72.92 - $102.01 $4.72 Million - $6.6 Million
64,702 New
64,702 $6.6 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Capital Impact Advisors, LLC Portfolio

Follow Capital Impact Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Impact Advisors, LLC with notifications on news.